Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.

ABOLISM Viral Proteins/GENETICS/*PHARMACOLOGY Clin Cancer Res. 2000 Mar;6(3):1180-9. Unique Identifier : AIDSLINE MED/20203794
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC; Department of Adult Oncology, Dana-Farber Cancer Institute,; Boston, Massachusetts 02115, USA.


Keywords: JOURNAL ARTICLE p42 MAP Kinase/DRUG EFFECTS/METABOLISM Animal Antibodies/PHARMACOLOGY Antigens, CD/DRUG EFFECTS/METABOLISM Cell Division/DRUG EFFECTS Cell Line Cell Survival/DRUG EFFECTS Dexamethasone/PHARMACOLOGY DNA-Binding Proteins/DRUG EFFECTS/METABOLISM Enzyme Activation/DRUG EFFECTS Enzyme Inhibitors/PHARMACOLOGY Flavones/PHARMACOLOGY Herpesvirus, Kaposi Sarcoma-Associated/GENETICS Human Hybridomas Interleukin-6/GENETICS/IMMUNOLOGY/*PHARMACOLOGY Membrane Glycoproteins/DRUG EFFECTS/METABOLISM Mice Mitogen-Activated Protein Kinase Kinases/ANTAGONISTS & INHIB Mitogen-Activated Protein Kinases/METABOLISM Neutralization Tests Phosphorylation/DRUG EFFECTS Protein-Serine-Threonine Kinases/ANTAGONISTS & INHIB Protein-Tyrosine Kinase/DRUG EFFECTS/METABOLISM Receptors, Interleukin-6/IMMUNOLOGY Recombinant Proteins/PHARMACOLOGY Signal Transduction/*DRUG EFFECTS Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Trans-Activators/DRUG EFFECTS/METABOLISM Tumor Cells, Cultured Tyrosine/METABOLISM Viral Proteins/GENETICS/*PHARMACOLOGY Clin Cancer Res. 2000 Mar;6(3):1180-9. Unique Identifier : AIDSLINE MED/20203794


000830
A0080985


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .